4//SEC Filing
Kelly Thomas Patrick 4
Accession 0001209191-23-053936
CIK 0001654151other
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 4:09 PM ET
Size
6.7 KB
Accession
0001209191-23-053936
Insider Transaction Report
Form 4
Kelly Thomas Patrick
Chief Financial Officer
Transactions
- Award
Common Stock
2023-10-28+8,244→ 65,384 total - Sale
Common Stock
2023-10-30$12.02/sh−2,316$27,833→ 63,068 total
Footnotes (2)
- [F1]On February 15, 2023, the Reporting Person was granted restricted stock units ("RSUs"), which vest upon the satisfaction of three performance criteria. On October 28, 2023, the Issuer's Compensation Committee confirmed that performance criteria two had been met, resulting in the vesting of 8,244 RSUs.
- [F2]This sale was to cover tax liabilities in the vesting of RSUs.
Documents
Issuer
Deciphera Pharmaceuticals, Inc.
CIK 0001654151
Entity typeother
Related Parties
1- filerCIK 0001410514
Filing Metadata
- Form type
- 4
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 4:09 PM ET
- Size
- 6.7 KB